Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2.
Ontology highlight
ABSTRACT: T-regulatory cells (T(regs)) are a rare lymphocyte subtype that shows promise for treating infectious disease, allergy, graft-versus-host disease, autoimmunity, and asthma. Clinical applications of T(regs) have not been fully realized because standard methods of expansion ex vivo produce heterogeneous progeny consisting of mixed populations of CD4 + T cells. Heterogeneous progeny are risky for human clinical trials and face significant regulatory hurdles. With the goal of producing homogeneous T(regs), we developed a novel expansion protocol targeting tumor necrosis factor receptors (TNFR) on T(regs). In in vitro studies, a TNFR2 agonist was found superior to standard methods in proliferating human T(regs) into a phenotypically homogeneous population consisting of 14 cell surface markers.
SUBMITTER: Okubo Y
PROVIDER: S-EPMC3818650 | biostudies-literature | 2013 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA